Detection of "oncometabolite" 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma
about
Molecular Imaging of Metabolic Reprograming in Mutant IDH CellsMalignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsOligodendroglioma: pathology, molecular mechanisms and markersMetabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryImproved localisation for 2-hydroxyglutarate detection at 3T using long-TE semi-LASERNeuro-oncology: Five new things.Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.Genetics and imaging of oligodendroglial tumors.Magnetic Resonance (MR) Metabolic Imaging in Glioma.MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.Emerging treatment strategies for glioblastoma multiformeCancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodelingMetabolomic signature of brain cancer.Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China.Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 Tesla.Non-invasive in vivo assessment of IDH1 mutational status in glioma.Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectivesMetabolic alteration in tumorigenesis.Tumor metabolism of malignant gliomas.Canine brain tumours: a model for the human disease?The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma.A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors.Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in gliomaNeomorphic mutations create therapeutic challenges in cancer.2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping.Biomarkers classification and therapeutic decision-making for malignant gliomas.Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas.Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients.A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).MR spectroscopy for in vivo assessment of the oncometabolite 2-hydroxyglutarate and its effects on cellular metabolism in human brain gliomas at 9.4T.Imaging Markers of Isocitrate Dehydrogenase-1 Mutations in Gliomas.Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate.Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis.900MHz 1H-/13C-NMR analysis of 2-hydroxyglutarate and other brain metabolites in human brain tumor tissue extracts
P2860
Q26750861-22D8EE1E-DC53-4D89-848E-EE2A0834293FQ26853516-182DC6F5-B066-4826-A583-F4AEA6DE9F82Q27002448-99FB11FA-CD8D-4E75-90E0-B4CD13146DEDQ27144251-3FEAE0E0-69FB-4725-8CB9-61D6CDD16DE6Q28829812-FE10AC52-9683-4CCD-9629-95B07D47DCEBQ30415098-9A15BB71-2753-4D7E-93C6-9DFFD33B5E6FQ30664676-7800C494-23C0-43C9-BAE0-FF177D3BB245Q31007575-9ADB8A1E-9D33-4131-9B43-3FBC4F6055DAQ31015256-17DB75BD-B6EC-4864-AC69-D282AC42174AQ31137181-DDC23A4A-DF56-448F-98C9-9FC291559299Q34542656-34E0D159-FF46-4802-A31D-D6AA08F28830Q36228895-DDF3C3EA-4340-4688-B6E2-B691314966BAQ36406413-339E49D8-05C9-4546-8518-4918386B0580Q36759382-1E5B6A6E-E583-4143-9133-55A904647563Q37240701-1BABF3EE-B5A8-4689-8AF8-FBA8648B851EQ37278758-8B172C00-261C-4936-818B-95AF7902B940Q37537230-075C83EE-3D42-4B99-993D-B0B6A1B8F4B6Q37730613-1E12C54E-D18E-4F71-82AE-2D14F483CFDFQ38052534-44F43007-4F54-44DD-8B26-AA35A946F733Q38151521-B0924614-0319-4F60-A97A-02ABCE00F74FQ38161749-5876CE30-DF0A-4822-8F97-87A344DCCDCFQ38491009-4FE330B0-ABF8-4336-BF9A-C6158514A610Q38623610-DACAF248-D0FA-4C42-BE2E-4DF8FF5545A2Q38694204-8E14978B-CE3B-47BC-8ECF-6F8F1D1FFD43Q38712122-D153E8AA-A23A-4A9E-A2B5-616806ED21C4Q38890122-42E46998-ABC6-4386-BA3A-F52B49EF6AD0Q38990221-BF32207C-4B47-4722-95A3-1A7454059FFEQ39007820-97913960-C7CE-4655-969D-D806021431DAQ39382153-A142CEA9-ADB5-48CC-87D5-EB2E02EE7E11Q39556985-0820D65D-F91A-4AFB-9EA7-BD64B4E8CBF0Q42075958-555D0128-12FA-45B0-8A57-E72A53045E9BQ42246513-FE4EE2DB-E6A5-4A51-84C6-E58EC7F09DBDQ42702324-52847179-4603-4897-987C-B88779D5864CQ45066734-9A5A9CC5-F5E0-434B-97BA-B8A4154AE971Q48838786-25107B2F-B5E8-41B2-9A78-9187F42F8F94Q52151986-BA1B4C74-688D-4D04-87E7-50834E7D3DEEQ52584624-E0FD82B3-42AC-48C5-A637-8384E66F3751Q54948216-38659652-C386-42AE-850E-F64765CE0E9CQ58760208-4E324FAF-FF01-4182-9F85-F8DF6ABD13AD
P2860
Detection of "oncometabolite" 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@ast
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@en
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@nl
type
label
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@ast
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@en
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@nl
prefLabel
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@ast
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@en
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@nl
P2093
P2860
P1476
Detection of "oncometabolite" ...... of IDH1/2 mutations in glioma
@en
P2093
Anne Carroll
Danny E Mancheno
Juliya Kalinina
Shaoxiong Wu
P2860
P2888
P304
P356
10.1007/S00109-012-0888-X
P577
2012-03-17T00:00:00Z
P5875
P6179
1010389754